Noninvasive Determination of Epidermal and Stratum Corneum Thickness in vivo Using Two-Photon Microscopy and Optical Coherence Tomography: Impact of Body Area, Age, and Gender

Background: High-resolution images of the epidermis are important to understand the transdermal penetration and changes in epidermal components. Both ex vivo and in vivo technologies are available to picture the epidermal thickness (ET). So far, the illustration of the stratum corneum (SC) has not been possible without artifacts. Objective: Precision in vivo measurement of the ET and SC, duly considering the impact of location on the body, age, and gender. Methods: In this pilot study on 20 skin-healthy subjects aged 18-66 years, the ET was imaged by two-photon microscopy (2PM) and optical coherence tomography (OCT), and the SC by using 2PM at five different body sites. Results: On solar-exposed body areas, both the epidermis and SC are thicker compared to solar-protected areas (p < 0.05), the epidermis at the gluteal region being the thickest (p < 0.05). The ET decreases with age (p < 0.05). Males show a thicker epidermis than females (p < 0.05). Conclusion: 2PM provides a noninvasive method for imaging the epidermis and especially the SC in vivo and is optimally suited for the application of histological criteria

EP-1122: Use of a dynamic thorax phantom for radiation dose determination of a floating target in Extracranial Stereotactic RT

n/

Use of antipsychotics and benzodiazepines in patients with psychiatric emergencies: Results of an observational trial

<p>Abstract</p> <p>Background</p> <p>Conventional antipsychotics augmented with benzodiazepines have been the standard acute treatment for psychiatric emergencies for more than 50 years. The inability of patients to give informed consent limits randomised, controlled studies. This observational study on immediate therapy for aggression and impulse control in acutely agitated patients (IMPULSE) evaluated the short-term effectiveness and tolerability of atypical and typical antipsychotic medications (AP) in a non-interventional setting.</p> <p>Methods</p> <p>This was a comparative, non-randomised, prospective, open-label, observational study. Treatment over the first 5 days was classified according to whether any olanzapine, risperidone, or haloperidol was included or not. Documentations (PANSS-excited component, CGI-aggression, CGI-suicidality, tranquilisation score) were at baseline (day 1) and days 2–6 after start of AP.</p> <p>Results</p> <p>During the short treatment-period, PANSS-EC and CGI-aggression scores improved in all cohorts. 68.7% of patients treated with olanzapine, 72.2% of patients treated with risperidone, and 83.3% of patients treated with haloperidol received concomitant benzodiazepines (haloperidol vs. non-haloperidol: p < 0.001). More patients treated with olanzapine (73.8%) were fully alert according to a tranquilisation score and active at day 2 than patients treated with risperidone (57.1%) or haloperidol (58.0%).</p> <p>Conclusion</p> <p>Current medication practices for immediate aggression control are effective with positive results present within a few days. In this study, concomitant benzodiazepine use was significantly more frequent in patients receiving haloperidol.</p

Luminescence properties of ZnO/Zn(1-x)CdxO/ZnO double heterostructures

We report on luminescence properties from T=2 K up to room temperature of ZnO/Zn(1-x)Cd(x)O/ZnO double heterostructures grown by pulsed-laser deposition on a-plane sapphire substrates. Depending on the growth conditions, the spectral position of the Zn(1-x)Cd(x)O related maximum has been tuned from 3.19 to 3.056 eV, corresponding approximately to Cd contents between 2.1% and 5.6%. Independent of x we observe intense phonon replicas of the photoluminescence (PL) maximum. The quenching of the luminescence intensity indicates the presence of two thermal activation energies, one of them being assigned to the delocalization of excitons from donors. The temperature-dependent PL spectra exhibit the so-called "S-shape" behavior as function of temperature for the Zn(1-x)Cd(x)O due to the superposition of the usual S-shape, caused by the alloy, and a change in the peak character from donor-bound exciton to free exciton. (C) 2010 American Institute of Physics. [doi: 10.1063/1.3372715]</p

Luminescence properties of ZnO/Zn(1-x)CdxO/ZnO double heterostructures

We report on luminescence properties from T=2 K up to room temperature of ZnO/Zn(1-x)Cd(x)O/ZnO double heterostructures grown by pulsed-laser deposition on a-plane sapphire substrates. Depending on the growth conditions, the spectral position of the Zn(1-x)Cd(x)O related maximum has been tuned from 3.19 to 3.056 eV, corresponding approximately to Cd contents between 2.1% and 5.6%. Independent of x we observe intense phonon replicas of the photoluminescence (PL) maximum. The quenching of the luminescence intensity indicates the presence of two thermal activation energies, one of them being assigned to the delocalization of excitons from donors. The temperature-dependent PL spectra exhibit the so-called "S-shape" behavior as function of temperature for the Zn(1-x)Cd(x)O due to the superposition of the usual S-shape, caused by the alloy, and a change in the peak character from donor-bound exciton to free exciton. (C) 2010 American Institute of Physics. [doi: 10.1063/1.3372715]</p